FDA to beef up quality focus in device approval process

FDA officials are enhancing their focus on quality during the medical device approval process, assures Steve Silverman, director of the office of compliance at the Center for Devices and Radiological Health. As MedCity News reports, Silverman spoke to a Minneapolis device industry audience about the agency's efforts to boost its focus on quality along with compliance. One way it will do this: A careful release of data to aid patients and providers seeking to determine which competing device is of higher quality. But Silverman said this would be more of a passive release of data, such as adverse events reports, inspection or recall data, and regulators will not issue device quality ratings. Story

Suggested Articles

Synthetic DNA weaver Twist Bioscience announced a handful of new collaborations this week amidst a $140 million raise from an underwritten offering.

The FDA has announced a series of actions aimed at limiting the use of power morcellators in gynecologic surgeries.

J&J launched a virtual clinical study to gauge whether Apple’s iPhone and ECG-enabled smartwatch can help reduce the risk of stroke and catch AFib.